Publication | Closed Access
Steroid hormone receptors in male breast diseases.
18
Citations
0
References
1987
Year
Breast OncologyTumor SamplesEndocrine-related CancerMale Tumor SamplesSteroid Hormone ReceptorsHormonal ReceptorGynecologyPathologyMale Breast CancerBreast CancerReceptor BiologyMenopauseEndocrinologyMedicineRadiation OncologySteroid MetabolismWomen's Health
Estrogen (ER), progesterone (PR), glucocorticoid (GR) and androgen (AR) receptors were assayed in tumor samples from 8 cases of male breast cancer (MBC) and 20 cases of male gynecomastia. Seven out of eight (87.5%) male tumor samples had positive ER assays with values ranging from 12 to 180 fmol/mg protein. Of the seven ER positive cases of MBC, six, had positive PR activity with high titers. Positive GR and AR values were also detected in 75% of MBC cases. Concentrations of all four receptors were significantly correlated with each other. With gynecomastic tissue, the proportion of receptor-positive patients was 20% ER, 20% PR, 20% AR, and 45% GR. Except for GR, steroid receptor values for MBC individuals were significantly higher than those of gynecomastia patients.